Philadelphia, April 24, 2024 – As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new ...
A newly published, post-hoc analysis of the landmark FUEL (Fontan Udenafil Exercise Longitudinal) Trial demonstrates that udenafil, a PDE5 inhibitor, significantly improves peak oxygen consumption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results